Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Trevi Therapeutics Inc (NQ: TRVI )

2.650 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.650
Bid (Size) 2.670 (8)
Ask (Size) 2.860 (4)
Prev. Close 2.650
Today's Range 2.650 - 2.650
52wk Range 0.9700 - 4.000
Shares Outstanding 60,069,512
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TRVI Stock Earnings: Trevi Therapeutics Beats EPS for Q4 2023
TRVI stock results show that Trevi Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Trevi Therapeutics: Q4 Earnings Insights
Via Benzinga

Performance

YTD
+103.85%
+103.85%
1 Month
-20.90%
-20.90%
3 Month
+98.50%
+98.50%
6 Month
+54.07%
+54.07%
1 Year
-9.56%
-9.56%

More News

Read More
Earnings Scheduled For March 20, 2024
Via Benzinga
Earnings Outlook For Trevi Therapeutics
Via Benzinga
Trevi Therapeutics's Earnings: A Preview
Via Benzinga
Recap: Trevi Therapeutics Q1 Earnings
Via Benzinga
Earnings Preview: Trevi Therapeutics
Via Benzinga
Earnings Outlook For Trevi Therapeutics
Via Benzinga
Trevi Therapeutics Shares Jump After Complete Data From Chronic Cough Trial
Via Benzinga
Earnings Scheduled For November 9, 2023
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For August 10, 2023
Via Benzinga
Earnings Scheduled For May 11, 2023
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 16, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
Via Benzinga
Trevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clinical Studies for Its Investigational Oral Therapy Haduvio(TM) with The Stock Day Podcast
Via Newsfile
Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Earnings Outlook For Trevi Therapeutics, Inc. - Common Stock
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Earnings Scheduled For November 10, 2022
Via Benzinga
Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.